Stago offers a comprehensive range for anticoagulant monitoring. STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH, fondaparinux, apixaban, rivaroxaban, edoxaban testing.
It is based on the inhibition of a known amount of factor Xa by the patient's sample heparin/DOAC. The residual factor Xa activity assessed by a colorimetric test will be inversely proportional to the heparin/DOAC concentration.
STA®-Liquid Anti-Xamain features are summarised in the table below:
| Features | Advantages | Benefits |
|---|---|---|
|
Liquid format: 4 & 8 mL |
· Ready-to-use: no reconstitution steps |
· Reduced handling time: · No waste of reagent: |
| Working range: UFH: 0.1 to 1.1 IU/mL LMWH: 0.1 to 2.0 IU Anti-Xa/mL FDX: 0.1 to 2.0 µg/mL |
· No re-dilutions · Allows to detect accumulation |
· User-friendly & secure: no analytical mistake |
| Calibration: Dedicated and hybrid calibrations |
· "The choice is yours" · Ease stock management: only 1 reference. |
· Total flexibility · Cost effective |
QC levels: UFH: 0.2 & 0.7 IU/mL LMWH: 0.8 & 1.4 IU Anti-Xa /mL |
· QC for each dose peak: represent the extreme situation | · Secure: follow-up of system performances at the limit of therapeutic ranges |
Fondaparinux, apixaban, rivaroxaban, edoxaban: Dedicated Calibration and QC kits |
Comply with recommendations (manufacturer, literature) | · User friendly & secure: eliminate risks of error |
Download the Anticoagulant Line sales brochure for more information on our products.